세계의 의료용 외골격 시장 : 산업 동향 및 세계 예측(-2035년) - 대상 부위별, 작동 모드별, 외골격 형태별, 이동성별, 최종사용자별, 주요 지역별 분석

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users, and Key Geographical Regions

US $ 4,799 ￦ 6,776,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,882,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,965,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,414,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

의료용 외골격 시장 규모는 2024년 19억 달러에 달할 것으로 예상되며, 예측 기간인 2024-2035년 20.8%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다.

의료용 외골격은 운동 장애를 가진 사람들을 돕기 위해 조정된 웨어러블 로봇 장치로, 기계, 전자 및 컴퓨터 제어 시스템의 융합을 사용하여 사용자의 움직임을 강화하고 정교하게 만듭니다. 일반적으로 부상이나 장애로 인해 영향을 받는 신체의 특정 부위에 특화된 이 장치는 휠체어나 목발과 같은 전통적인 보조기구와 차별화됩니다. 일부 전동식 외골격 기술은 액추에이터와 센서의 통합을 통해 사용자의 근력과 체력을 증폭시켜 능동적인 이동 지원을 제공합니다. 의료용 외골격의 잠재력은 방대하며, 이동 지원을 절실히 필요로 하는 많은 환자층에 공감을 불러일으킵니다. 특히 신경 장애는 전 세계 10억 명 이상의 사람들에게 영향을 미치는 공중 보건의 큰 문제입니다.

거동 장애로 고생하는 인구가 상당히 많음에도 불구하고, 외골격 시장은 점차 주목을 받고 있음에도 불구하고 상대적으로 틈새 시장으로 남아 있습니다. 이는 외골격 기술 관련 비용 상승, 환자와 의료진 모두에 대한 인식 부족 등 여러 가지 요인에 기인합니다. 그럼에도 불구하고, 현재 진행 중인 기술 발전과 인식 개선으로 의료용 외골격 시장은 확대될 태세를 갖추고 있으며, 이동 보조가 필요한 사람들의 접근성과 삶의 질을 향상시킬 수 있을 것으로 기대되고 있습니다. 실제로 여러 기업이 컨트롤러 및 소프트웨어 용도과 같은 고급 기능을 통합한 외골격 기술 개발에 앞장서고 있으며, 사용자 및 임상의가 목표를 설정하고, 보조 수준을 미세 조정하고, 개별 재활 계획에 맞게 동작 패턴을 면밀히 조사할 수 있도록 돕고 있습니다.

이 보고서는 세계 의료용 외골격 시장에 대해 조사했으며, 시장 개요와 함께 대상 부위별/동작 모드별/외골격 형태별/이동성별/최종사용자별/주요 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 조사 방법

제3장 경제 및 기타 프로젝트 특유의 고려사항

제4장 주요 요약

제5장 서론

제6장 의료용 외골격 : 시장 구도

• 본 장의 개요
• 의료용 외골격 : 시장 구도
• 의료용 외골격 : 개발자, 상황

제7장 의료용 외골격 : 제품 경쟁 분석

• 본 장의 개요
• 전제와 주요 파라미터
• 조사 방법
• 의료용 외골격 : 제품 경쟁 분석

제8장 외골격 개발 기업 : 상세한 기업 개요

• 본 장의 개요
• CYBERDYNE
• Ekso Bionics
• ExoAtlet
• Fourier Intelligence
• Gloreha
• Guangzhou Yikang
• Hexar Humancare
• Hocoma
• Panasonic
• Tyromotion

제9장 외골격 개발 기업 : 기업 개요 리스트

• 본 장의 개요
• Bionic Yantra
• MediTouch
• Milebot Robotics
• Myomo
• Neofect
• NextStep Robotics
• ReWalk Robotics
• Rex Bionics
• Roam Robotics
• Trexo Robotics
• U&O Technologies

제10장 의료용 외골격 : 파트너십과 협업

• 본 장의 개요
• 파트너십 모델
• 의료용 외골격 : 파트너십과 협업 리스트

제11장 특허 분석

제12장 블루 오션 전략

제13장 시장에 대한 영향 분석 : 성장 촉진요인 및 억제요인, 기회, 과제

• 본 장의 개요
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 시장이 해결해야 할 과제
• 결론

제14장 의료용 외골격 시장

• 본 장의 개요
• 예측 조사 방법과 주요 전제
• 의료용 외골격 시장, 과거 동향(2018년-2022년) 및 예측(2023년-2035년)
• 주요 시장 세분화
• 다이나믹·대시보드

제15장 외골격 시장, 대상 부위별

제16장 외골격 시장, 동작 모드별

제17장 외골격 시장, 형태별

제18장 외골격 시장, 모빌리티별

제19장 외골격 시장, 최종사용자별

제20장 외골격 시장, 지역별

• 본 장의 개요
• 예측 조사 방법과 주요 전제
• 북미
• 유럽
• 아시아태평양
• 기타 지역
• 데이터 삼각측량과 검증

제21장 결론

제22장 주요 인사이트

제23장 부록 1 블루 오션 전략과 시프트 툴

제24장 부록 2 표 데이터

제25장 부록 3 기업 및 조직 리스트

LSH

영문 목차

영문목차

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered (Upper Body, Lower Body and Full Body), Mode of Operation (Powered, Passive and Hybrid), Form of Exoskeleton (Rigid and Soft), Mobility (Fixed / Supported and Mobile), End Users (Patients and Healthcare Providers), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)

The Medical Exoskeleton Market is valued at USD 1.90 billion in 2024 growing at a CAGR of 20.8% during the forecast period 2024-2035.

Medical exoskeletons, wearable robotic devices tailored to aid individuals with mobility impairments, harness a blend of mechanical, electronic, and computer-controlled systems to bolster and refine the user's movement. Typically, homing in on specific body parts affected by injury or disability, these devices diverge from conventional assistive tools like wheelchairs and crutches. Certain iterations of powered exoskeleton technology furnish active mobility assistance by amplifying the user's strength and stamina through the integration of actuators and sensors. The potential of medical exoskeletons is vast, resonating with a considerable patient demographic in dire need of mobility support. Neurological disorders, in particular, pose a formidable public health challenge, impacting over one billion individuals worldwide. Traumatic brain injury (TBI), as highlighted by the Lancet Neurology Commission, stands as a pervasive global concern afflicting 55 million people, while current estimates suggest a populace of 20.6 million grappling with spinal cord injury.

Despite the substantial population contending with mobility impairments, the exoskeleton market maintains a relatively niche status, albeit gradually garnering attention. This can be attributed to various factors, including the elevated costs associated with exoskeleton technology and a prevalent lack of awareness among both patients and healthcare providers. Nonetheless, with ongoing technological strides and heightened awareness, the medical exoskeleton market stands poised for expansion, offering the promise of enhanced accessibility and quality of life for those in need of mobility assistance. Indeed, several companies are spearheading the development of exoskeleton technology fused with advanced features such as controllers and software applications, empowering users and clinicians alike to establish goals, fine-tune assistance levels, and scrutinize movement patterns tailored to personalized rehabilitation plans.

Key Market Segments

Body Part Covered

• Upper Extremity
• Lower Extremity
• Full Body

Mode of Operation

• Powered
• Passive
• Hybrid

Form

• Rigid
• Soft

Mobility

• Fixed / Supported
• Mobile

End Users

• Patients
• Healthcare Providers

Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World

Research Coverage:

• An insightful overview of exoskeleton industry, highlighting details on origin of exoskeletons. This chapter provides information on classification of exoskeleton, along with applications, features and limitations associated with exoskeleton. Further, it concludes with a discussion on future perspectives in this domain.
• This overview provides insight into the current market landscape of medical exoskeletons, considering various parameters such as development status (commercialized and under development), body part coverage (upper extremity, lower extremity, and full body), mode of operation (powered, passive, and hybrid), exoskeleton form (rigid and soft exosuit), mobility (stationary and mobile), user-machine interface (including app-based, handheld controller, on-device buttons/control panels, and brain control), and advanced features (such as data capture, gamification, and customized assistance). Additionally, it addresses end users (patients, medical professionals, and researchers), patient age groups (pediatric to adolescent, adolescent to elderly), and exoskeleton settings (home/community and rehabilitation centers). It also touches on breakthrough device designations, exoskeleton technology/software, maximum weight, weight carrying capacity, and dimensions. Furthermore, it lists companies involved in medical exoskeleton development/commercialization, providing details on establishment year, company size, headquarters location, ownership, and additional services. Lastly, it highlights the most active companies in terms of medical exoskeleton offerings.
• A comprehensive analysis of product competitiveness within the medical exoskeleton market, focusing on supplier strength (including years of experience, company size, and exoskeleton portfolio), product competitiveness (encompassing device mobility, exoskeleton form, operation mode, advanced features, user-machine interface, additional services, breakthrough designation, and development status), and target end users.
• Comprehensive profiles of prominent medical exoskeleton companies selected based on the quantity and application scope of wearable exoskeletons in their product lineup. Each profile provides a succinct overview of the company, including establishment year, employee count, headquarters location, and leadership team details, along with insights into financial performance where applicable. Additionally, the profiles encompass information on the company's product range, recent advancements, and an informed perspective on future prospects.
• Tabulated summaries of leading medical exoskeleton companies selected based on the quantity and application range of wearable exoskeletons in their product offerings. Each tabulated profile provides an overview of the company, detailing establishment year, employee count, headquarters location, and key leadership team members. Additionally, the profiles include information on the company's product portfolio.
• A comprehensive analysis of the medical exoskeleton market's recent partnerships and collaborations established since 2017. This analysis considers various parameters, including the year of partnership, partnership type (such as mergers and acquisitions, product development and commercialization agreements, licensing agreements, service agreements, product development and manufacturing agreements, joint ventures, manufacturing and supply agreements, and product distribution agreements), partner type (industry and non-industry), business globalization trends, and the most active players. Additionally, it provides insights into the regional distribution of the companies engaged in these agreements.
• A thorough examination of patents filed or granted for exoskeletons since 2016, encompassing diverse relevant factors such as patent type, application and publication years, geographical origins, applicant types, publication timelines, top CPC symbols, and key players in terms of the quantity of patents filed or granted. Additionally, it includes an in-depth patent benchmarking analysis.
• An exhaustive examination of the present and prospective market through the lens of the Blue Ocean Strategy, providing a strategic roadmap for nascent medical exoskeleton enterprises to tap into uncontested market spaces. This guide encompasses thirteen strategic tools aimed at facilitating a transition towards a Blue Ocean strategy, enabling companies to secure a competitive advantage in the market.
• A comprehensive examination of the factors influencing the expansion of the medical exoskeleton market. This analysis includes the identification and evaluation of significant drivers, potential limitations, emerging prospects, and current obstacles.

Key Benefits of Buying this Report

• The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a pulse on the Medical Exoskeleton Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

• Bionic Yantra

CYBERDYNE

• Ekso Bionics
• ExoAtlet
• Fourier Intelligence
• Gloreha
• Guangzhou Yikang Medical Equipment
• Hexar Humancare
• Hocoma
• MediTouch
• Milebot Robotics
• Myomo
• Neofect
• NextStep Robotics
• Panasonic
• ReWalk Robotics
• Rex Bionics
• Roam Robotics
• Trexo Robotics
• Tyromotion
• U&O Technologies

TABLE OF CONTENTS

Table Of Contents

1. PREFACE

• 1.1. Introduction
• 1.2. Key Market Insights
• 1.3. Scope of the Report
• 1.4. Research Methodology
• 1.5. Frequently Asked Questions
• 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
• 2.3. Project Methodology
• 2.4. Forecast Methodology
• 2.5. Robust Quality Control
• 2.6. Key Market Segmentations
• 2.7. Key Considerations
  • 2.7.1. Demographics
  • 2.7.2. Economic Factors
  • 2.7.3. Government Regulations
  • 2.7.4. Supply Chain
  • 2.7.5. COVID Impact / Related Factors
  • 2.7.6. Market Access
  • 2.7.7. Healthcare Policies
  • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

• 3.1. Chapter Overview
• 3.2. Market Dynamics
  • 3.2.1. Time Period
    • 3.2.1.1. Historical Trends
    • 3.2.1.2. Current and Forecasted Estimates
  • 3.2.2. Currency Coverage
    • 3.2.2.1. Overview of Major Currencies Affecting the Market
    • 3.2.2.2. Impact of Currency Fluctuations on the Industry
  • 3.2.3. Foreign Exchange Impact
    • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
    • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 3.2.4. Recession
    • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 3.2.5. Inflation
    • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

• 5.1. Chapter Overview
• 5.2. Overview of Exoskeleton
• 5.3. History of Exoskeleton
• 5.4. Classification of Exoskeleton
  • 5.4.1. Based on Body Part Supported
  • 5.4.2. Based on Form of Exoskeleton
  • 5.4.3. Based on Mode of Operation
  • 5.4.4 Based on Mobility
• 5.5. Applications of Exoskeleton
• 5.6. Features of Exoskeleton
• 5.7. Limitations of Exoskeleton
• 5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE

• 6.1. Chapter Overview
• 6.2. Medical Exoskeleton: Overall Market Landscape
  • 6.2.1. Analysis by Status of Development
  • 6.2.2. Analysis by Type of Body Part Covered
  • 6.2.3. Analysis by Mode of Operation
  • 6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
  • 6.2.5. Analysis by Form of Exoskeleton
  • 6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
  • 6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
  • 6.2.8. Analysis by Device Mobility
  • 6.2.9. Analysis by Mode of Operation and Device Mobility
  • 6.2.10. Analysis by Form of Exoskeleton and Device Mobility
  • 6.2.11. Analysis by Type of Body Part Covered and Device Mobility
  • 6.2.12. Analysis by User-Machine Interface
  • 6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
  • 6.2.14. Analysis by Mode of Operation and User-Machine Interface
  • 6.2.15. Analysis by Availability of Advanced Features
  • 6.2.16. Analysis by End User
  • 6.2.17. Analysis by Patient Age Group
  • 6.2.18. Analysis by Exoskeleton Setting for Patients
  • 6.2.19. Analysis by Breakthrough Designation
• 6.3. Medical Exoskeleton: Developer: Landscape
  • 6.3.1. Analysis by Year of Establishment
  • 6.3.2. Analysis by Company Size
  • 6.3.3. Analysis by Location of Headquarters
  • 6.3.4. Analysis by Company Size and Location of Headquarters
  • 6.3.5. Analysis by Company Ownership
  • 6.3.6. Analysis by Location of Headquarters and Company Ownership
  • 6.3.7. Analysis by Additional Services Offered
  • 6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton

7. MEDICAL EXOSKELETON: PRODUCT COMPETITIVENESS ANALYSIS

• 7.1 Chapter Overview
• 7.2. Assumptions and Key Parameters
• 7.3. Methodology
• 7.4. Medical Exoskeleton: Product Competitiveness Analysis
  • 7.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
    • 7.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
    • 7.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
    • 7.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
  • 7.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
    • 7.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
    • 7.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
    • 7.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
  • 7.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton

8. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

• 8.1. Chapter Overview
• 8.2. CYBERDYNE
  • 8.2.1. Company Overview
  • 8.2.2. Financial Information
  • 8.2.3. Product Portfolio
  • 8.2.4 Recent Developments and Future Outlook
• 8.3. Ekso Bionics
  • 8.3.1. Company Overview
  • 8.3.2. Financial Information
  • 8.3.3. Product Portfolio
  • 8.3.4 Recent Developments and Future Outlook
• 8.4. ExoAtlet
  • 8.4.1. Company Overview
  • 8.4.2. Product Portfolio
  • 8.4.3. Recent Developments and Future Outlook
• 8.5. Fourier Intelligence
  • 8.5.1. Company Overview
  • 8.5.2. Product Portfolio
  • 8.5.3. Recent Developments and Future Outlook
• 8.6. Gloreha
  • 8.6.1. Company Overview
  • 8.6.2. Product Portfolio
  • 8.6.3. Recent Developments and Future Outlook
• 8.7. Guangzhou Yikang
  • 8.7.1. Company Overview
  • 8.7.2. Product Portfolio
  • 8.7.3. Recent Developments and Future Outlook
• 8.8. Hexar Humancare
  • 8.8.1. Company Overview
  • 8.8.2. Product Portfolio
  • 8.8.3. Recent Developments and Future Outlook
• 8.9. Hocoma
  • 8.9.1. Company Overview
  • 8.9.2. Product Portfolio
  • 8.9.3. Recent Developments and Future Outlook
• 8.10. Panasonic
  • 8.10.1. Company Overview
  • 8.10.2. Financial Information
  • 8.10.3. Product Portfolio
  • 8.10.4. Recent Developments and Future Outlook
• 8.11. Tyromotion
  • 8.11.1. Company Overview
  • 8.11.2. Product Portfolio
  • 8.11.3. Recent Developments and Future Outlook

9. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

• 9.1. Chapter Overview
• 9.2. Bionic Yantra
• 9.3. MediTouch
• 9.4. Milebot Robotics
• 9.5. Myomo
• 9.6. Neofect
• 9.7. NextStep Robotics
• 9.8. ReWalk Robotics
• 9.9. Rex Bionics
• 9.10. Roam Robotics
• 9.11. Trexo Robotics
• 9.12. U&O Technologies

10. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS

• 10.1. Chapter Overview
• 10.2. Partnership Models
• 10.3. Medical Exoskeleton: List of Partnerships and Collaborations
  • 10.3.1. Analysis by Year of Partnership
  • 10.3.2. Analysis by Type of Partnership
  • 10.3.3. Analysis by Year and Type of Partnership
  • 10.3.4. Analysis by Type of Partner
  • 10.3.5. Analysis by Year of Partnership and Type of Partner
  • 10.3.6. Analysis by Purpose of Partnership
  • 10.3.7. Analysis by Geography
    • 10.3.7.1. Local and International Agreements
    • 10.3.7.2. Intracontinental and Intercontinental Agreements
    • 10.3.7.3. Most Active Players: Distribution by Number of Partnerships

11. PATENT ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
• 11.3. Exoskeleton: Patent Analysis
  • 11.3.1. Analysis by Patent Application Year
  • 11.3.2. Analysis by Patent Publication Year
  • 11.3.3. Analysis by Type of Patent and Patent Publication Year
  • 11.3.4. Analysis by Publication Time
  • 11.3.5. Analysis by Patent Jurisdiction
  • 11.3.6. Analysis by CPC symbols
  • 11.3.7. Analysis by Type of Applicant
  • 11.3.8. Leading Players: Analysis by Number of Patents
  • 11.3.9. Leading Patent Assignees: Analysis by Number of Patents
• 11.4. Exoskeleton: Patent Benchmarking
  • 11.4.1. Analysis by Patent Characteristics
  • 11.4.2. Exoskeleton: Patent Valuation
• 11.5. Leading Players by Number of Citations

12. BLUE OCEAN STRATEGY

• 12.1. Overview of Blue Ocean Strategy
  • 12.1.1. Red Oceans
  • 12.1.2. Blue Oceans
  • 12.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
  • 12.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
    • 12.1.4.1. Strategy Canvas
    • 12.1.4.2. Pioneer-Migrator-Settler (PMS) Map
    • 12.1.4.3. Buyer Utility Map

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 13.1. Chapter Overview
• 13.2. Market Drivers
• 13.3. Market Restraints
• 13.4. Market Opportunities
• 13.5. Market Challenges
• 13.6. Conclusion

14. MEDICAL EXOSKELETON MARKET

• 14.1. Chapter Overview
• 14.2. Forecast Methodology and Key Assumptions
• 14.3. Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.3.1. Scenario Analysis
• 14.4. Key Market Segmentations
• 14.5. Dynamic Dashboard

15. EXOSKELETON MARKET, BY BODY PART COVERED

• 15.1. Chapter Overview
• 15.2. Forecast Methodology and Key Assumptions
• 15.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 15.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 15.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 15.6. Data Triangulation and Validation

16. EXOSKELETON MARKET, BY MODE OF OPERATION

• 16.1. Chapter Overview
• 16.2. Forecast Methodology and Key Assumptions
• 16.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 16.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 16.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 16.6. Data Triangulation and Validation

17. EXOSKELETON MARKET, BY THEIR FORM

• 17.1. Chapter Overview
• 17.2. Forecast Methodology and Key Assumptions
• 17.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 17.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 17.5. Data Triangulation and Validation

18. EXOSKELETON MARKET, BY THEIR MOBILITY

• 18.1. Chapter Overview
• 18.2. Forecast Methodology and Key Assumptions
• 18.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 18.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 18.5. Data Triangulation and Validation

19. EXOSKELETON MARKET, BY END USERS

• 19.1. Chapter Overview
• 19.2. Forecast Methodology and Key Assumptions
• 19.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 19.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 19.5. Data Triangulation and Validation

20. EXOSKELETON MARKET, BY GEOGRAPHY

• 20.1. Chapter Overview
• 20.2. Forecast Methodology and Key Assumptions
• 20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.7. Data Triangulation and Validation

21. CONCLUSION

22. EXECUTIVE INSIGHTS

• 22.1. Chapter Overview
• 22.2. Spain-based Small Company
  • 22.2.1. Company Snapshot
  • 22.2.2. Interview Transcript: Co-Founder and Chief Executive Officer
• 22.3. Japan-based Small Company
  • 22.3.1. Company Snapshot
  • 22.3.2. Interview Transcript: Director of Business Planning and Development
• 22.4. US-based Small Company
  • 22.4.1. Company Snapshot
  • 22.4.2. Interview Transcript: Vice President of Sales and Marketing
• 22.5. Canada-based Small Company
  • 22.5.1. Company Snapshot
  • 22.5.2. Interview Transcript: Marketing and Design Manager
• 22.6. India-based Small Company
  • 22.6.1. Company Snapshot
  • 22.6.2. Interview Transcript: Founder and Director

23. APPENDIX 1: BLUE OCEAN STRATEGY AND SHIFT TOOLS

24. APPENDIX 2: TABULATED DATA

25. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATION

관련자료